Female Sexual Dysfunction Global Clinical Trials Review, H2, 2015

1
Female Sexual Dysfunction Global Clinical Trials
Review, H2, 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Female Sexual Dysfunction Global Clinical Trials
  Review, H2, 2015 provides an overview of Female
  Sexual Dysfunction clinical trials scenario. This
  report provides top line data relating to the
  clinical trials on Female Sexual Dysfunction.
  Report includes an overview of trial numbers and
  their average enrollment in top countries
  conducted across the globe. The report offers
  coverage of disease clinical trials by region,
  country (G7 E7), phase, trial status, end
  points status and sponsor type. Report also
  provides prominent drugs for in-progress trials
  (based on number of ongoing trials).
• Scope
• - The report provides a snapshot of the global
  clinical trials landscape
• - Report provides top level data related to the
  clinical trials by Region, Country (G7 E7),
  Trial Status, Trial Phase, Sponsor Type and End
  point status
• - The report reviews top companies involved and
  enlists all trials (Trial title, Phase, and
  Status) pertaining to the company
• - The report provides all the unaccomplished
  trials (Terminated, Suspended and Withdrawn) with
  reason for unaccomplishment
• - The Report provides enrollment trends for the
  past five years
• - Report provides latest news for the past three
  months
• Read More At http//www.researchbeam.com/female-s
  exual-dysfunction-global-clinical-trials-review-h2
  -2015-market

3


Table of Content
Table of Contents 2 List of Tables 3 List of
Figures 4 Report Guidance 5 Clinical Trials by
Region 6 Clinical Trials and Average Enrollment
by Country 7 Top Five Countries Contributing to
Clinical Trials in Asia-Pacific 10 Top Five
Countries Contributing to Clinical Trials in
Europe 11 Top Countries Contributing to Clinical
Trials in North America 12 Top Five Countries
Contributing to Clinical Trials in Middle East
and Africa 13 Top Countries Contributing to
Clinical Trials in Central and South America
14 Clinical Trials by G7 Countries Proportion of
Female Sexual Dysfunction to Women's Health
Clinical Trials 15 Clinical Trials by Phase in G7
Countries 17 Clinical Trials in G7 Countries by
Trial Status 18 Clinical Trials by E7 Countries
Proportion of Female Sexual Dysfunction to
Women's Health Clinical Trials 19 Clinical Trials
by Phase in E7 Countries 21 Clinical Trials in E7
Countries by Trial Status 22 Clinical Trials by
Phase 23 In Progress Trials by Phase 24  
4


Table of Content
Clinical Trials by Trial Status 25 Clinical
Trials by End Point Status 27 Subjects Recruited
Over a Period of Time 28 Clinical Trials by
Sponsor Type 29 Prominent Sponsors 30 Top
Companies Participating in Female Sexual
Dysfunction Therapeutics Clinical Trials
32 Prominent Drugs 34 Latest Clinical Trials News
on Female Sexual Dysfunction 35 Oct 28, 2015
Strategic Science and Technologies Initiates
Phase 2 Study to Evaluate Topical Sildenafil in
Women with Female Sexual Arousal Disorder
35 Clinical Trial Profile Snapshots 36 Appendix
146 Abbreviations 146 Definitions 146 Research
Methodology 147 Secondary Research 147 About
GlobalData 148 Contact Us 148 Disclaimer
148 Source 149 Enquire At http//www.researchbe
am.com/female-sexual-dysfunction-global-clinical-t
rials-review-h2-2015-market/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/female-sexual-dysfunct
ion-global-clinical-trials-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com